Market Place
Sourcing Support
MorphoSys cuts R&D from Constellation deal to focus on cancer drugs
11 Mar 2022 //
MEDCITYNEWS
Gilead`s Immunomedics CMO exits to Aadi as it nears FDA decision
26 Oct 2021 //
FIERCEBIOTECH
Magenta nabs Constellation CMO after 5-month search, trial snag
04 Oct 2021 //
FIERCEBIOTECH
Magenta nabs Constellation CMO after 5-month search, trial snag
04 Oct 2021 //
FIERCEBIOTECH
Morphosys to buy Constellation in $1.7B deal, aided by unusual funding
03 Jun 2021 //
BIOPHARMADIVE
Constellation Appoints Brendan Delaney as Chief Commercial Officer
07 Jan 2021 //
GLOBENEWSWIRE
Constellation to Host Analyst / Investor Event of MANIFEST Trial for CPI-0610
23 Nov 2020 //
GLOBENEWSWIRE
Constellation Announces Pricing of PO of Common Stock - June 17, 2020
16 Jun 2020 //
BIOSPACE
Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610
11 Jun 2020 //
GLOBENEWSWIRE
Constellation Pharmaceuticals Provides Update of Preliminary Data for CPI-0610
14 May 2020 //
GLOBENEWSWIRE
Constellation Pharmaceuticals: A Recent IPO Of Interest
21 Aug 2018 //
SEEKING ALPHA
A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casino
16 Jul 2018 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.